Enterprise Social Learning in the Pharma Industry – Case Study from IBM

According to IDC, IBM Connections is the market leader in the Enterprise Social Collaboration market (aka Enterprise Social Learning). With a market share that is twice as large as Jive, IBM’s product has widespread usage among notoriously difficult markets such as pharmaceutical companies that need strict controls on data security and conversational relevance.

Pharma companies are facing significant challenges in the areas of drug discovery and innovation. A lot of products are going out of patent protection (and generics are moving in), Governments are openly revolting against the high cost of medications by overriding patent regimes (as in the case of the Indian Government that ticked off Bayer over its cancer drug), cost of innovation and drug discovery has gone up, and most importantly, Pharma companies have the unenviable task of performing a complex choreography to bring together islands of geographically dispersed talent.

And to top it off, we are seeing disruptive changes happening on the consumer side with mobile apps, gene mapping, and internet coming together to provide unprecedented data and control to consumers. I personally believe that Doctors will eventually (not in the near future) become less important as tools, information, and actionable knowledge force pharma companies to transform themselves into consumer electronics companies (If this sounds outrageous, I wrote this post after standing out in the hot California summer Sun and this might have re-wired my brain cells). If you would like to explore this thought a little more, check out “The Creative Destruction of Medicine – How the Digital Revolution will create better Healthcare” by  Dr. Eric Topol.

Considering these current and emerging challenges, Pharma companies need every dose of technology and innovation (pun intended) to stay healthy (once again pun intended) and remain competitive. And ironically, Bayer is one of those companies that has embraced IBM Connections. Check out the video of Bayer’s CIO of Material Sciences Division talking about how IBM Connections is being used by Bayer to collaborate and innovate and even mentions that all other divisions of Bayer will eventually start using the product.

Srinivas Krishnaswamy

Advertisements

I love to read and share thoughts on technology, enterprise learning, mobile and any thing cool that impacts enterprises.

Tagged with: , , , ,
Posted in Social Learning
2 comments on “Enterprise Social Learning in the Pharma Industry – Case Study from IBM
  1. […] Bayer’s Material Sciences Division decided to become more collaborative, they realized that the main challenge in promoting knowledge-sharing across organizational […]

  2. […] Bayer’s Material Sciences Division decided to become more collaborative, they realized that the main challenge in promoting knowledge-sharing across organizational […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to follow this blog and receive notifications of new posts by email.

Archives
%d bloggers like this: